Fermenta Biotech Ltd. (FERMENTA): Fermenta Biotech Share Price Rises 8.23% Today

Fermenta Biotech Share Price is in focus today after the stock rose 8.23% to Rs 526.60 from its previous close of Rs 486.55. The company’s market capitalisation stands at Rs 1,471.99 Cr, placing the move in a mid-cap context within the Indian stock market. The latest Univest data confirms a clear price rise, while the data set does not establish a company-specific catalyst for the move. For readers tracking Fermenta Biotech Share Price Today, the immediate question is how this share price rise fits with valuation, sector positioning and peer comparison. Univest is therefore useful here not as a prediction tool, but as a structured way to follow Fermenta Biotech Share Price, Fermenta Biotech Stock News and Fermenta Biotech Share Price News in one place.

As of 02 September 2026 at 3:32:39 PM IST, the stock had also traded between Rs 478.15 and Rs 526.70, with the day opening matching the previous close at Rs 486.55. That combination points to a strong intraday re-rating, even as no company-specific trigger is confirmed. For investors asking why Fermenta Biotech is rising today, the verified data supports the move itself, not a fresh announcement. Univest tracks this kind of share price update by pairing live market action with valuation and sector context.

Fermenta Biotech Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 526.6
Previous Close	Rs 486.55
Today's Move	Rs 40.05 (+8.23%)
Open	Rs 486.55
High	Rs 526.7
Low	Rs 478.15
Turnover	Rs 1.11 crore
Market Capitalisation	Rs 1,471.99 crore
Market Cap Category	Small Cap

Fermenta Biotech Ltd. (FERMENTA) rose to Rs 526.6 from the previous close of Rs 486.55, a move of Rs 40.05 or 8.23%. The stock opened at Rs 486.55, reached a high of Rs 526.7, recorded a low of Rs 478.15.

Fermenta Biotech Share Price Today shows a sharp intraday gain of Rs 40.05, or 8.23%, with the stock last traded at Rs 526.60. The session opened at Rs 486.55, moved as low as Rs 478.15 and touched Rs 526.70 at the high end, keeping the move firmly in positive territory throughout the session. Turnover stood at Rs 1.11 Cr. For Fermenta Biotech Share Price, the main takeaway is simple: today’s price action reflects a strong rise, but the verified market data alone does not establish a specific stock news trigger.

Fermenta Biotech Ltd. (FERMENTA) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 1,471.99 crore
P/E Ratio	23.67x
P/B Ratio	3.47x
ROE	18.36%
ROCE	21.99%
EPS	Rs 20.55
Book Value Per Share	Rs 140.3
Dividend Yield	0.77%

Fermenta Biotech Ltd. (FERMENTA) fundamental metrics show P/E 23.67x, P/B 3.47x, ROE 18.36%, ROCE 21.99%. These figures provide context only and are not a buy or sell signal.

Fermenta Biotech Ltd. has a market capitalisation of Rs 1471.99 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 23.67x, P/B at 3.47x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.36% and ROCE of 21.99%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 20.55, book value per share of Rs 140.3, dividend yield of 0.77%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.29x, median ROE of 11.79%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	23.67x
Benchmark Median P/E	31.29x
Benchmark Average P/E	48.12x
Benchmark P/E Range	3.68x to 653.31x
Company P/B Ratio	3.47x
Benchmark Median P/B	2.88x
Company ROE	18.36%
Benchmark Median ROE	11.79%
Company ROCE	21.99%
Benchmark Median ROCE	13.63%
Company Market Capitalisation	Rs 1,471.99 crore
Benchmark Median Market Cap	Rs 720.34 crore

Fermenta Biotech Ltd. (FERMENTA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Fermenta Biotech Ltd. (FERMENTA) has a P/E ratio of 23.67x, which is below the benchmark median of 31.29x, a difference of -24.35%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Fermenta Biotech Ltd. (FERMENTA) has a ROE of 18.36%, which is above the benchmark median of 11.79%, a difference of +55.73%. Fermenta Biotech Ltd. (FERMENTA) has a ROCE of 21.99%, which is above the benchmark median of 13.63%, a difference of +61.34%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,69,309.92	38.29	5.36	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,45,425.7	83.18	13.77	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,89,347.12	86.48	21.02	26.76	19.27
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,15,919.92	25.73	4.31	19.69	21.39
Cipla Ltd.	CIPLA	1,14,392.76	33.99	3.26	11.83	16

Fermenta Biotech Ltd. (FERMENTA) has a P/E ratio of 23.67x compared with the displayed peer median of 38.29x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.36% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 21.99% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Fermenta Biotech Ltd. (FERMENTA) has a market capitalisation of Rs 1,471.99 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Fermenta Biotech

• Fermenta Biotech Share Price is trading 8.23% higher, with Rs 40.05 added to the previous close.
• The move came without a verified company-specific catalyst, so the price action itself is the key event.
• Fermenta Biotech Fundamental Analysis shows a P/E of 23.67, P/B of 3.47, ROE of 18.36% and ROCE of 21.99%.
• The stock trades in the Healthcare sector and Pharmaceuticals & Drugs industry, where peer valuations vary sharply.
• Fermenta Biotech Share Price Today is being watched for whether the latest market interest extends into the next market update.

About Fermenta Biotech

Fermenta Biotech Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. Based on the latest Univest figures, the company is being tracked as a listed Indian pharma-linked business whose market identity sits within a broad healthcare ecosystem that includes large diversified drug makers, specialty names and formulation-focused companies. That industry setting matters because Fermenta Biotech Share Price is often read alongside peers with very different size, return and valuation profiles.

For readers following Fermenta Biotech Stock News, the main point is that the company belongs to a sector where profitability, capital efficiency and pricing power often influence how the market values a stock. Today’s share price rise does not by itself rewrite the business story, but it does make the company more visible in Market News and Share Market Today searches. Univest keeps the company view attached to the live price action so that Fermenta Biotech Share Price, Fermenta Biotech Share Price Live and Fermenta Biotech Latest News can be followed in one place.

Frequently Asked Questions

Why is Fermenta Biotech Share Price rising today?

Ans. Fermenta Biotech Share Price is up 8.23% today, but the latest market data does not confirm a company-specific catalyst. The move is visible in price action, previous close and intraday range, not in a verified news trigger.

What is Fermenta Biotech Share Price Today?

Ans. Fermenta Biotech Share Price Today is Rs 526.60. It is up from the previous close of Rs 486.55, reflecting a Rs 40.05 gain during the session and keeping the stock in active market focus.

How much did Fermenta Biotech stock rise today?

Ans. Fermenta Biotech stock rose 8.23% in the latest session. The move lifted the price to Rs 526.60 and placed the stock among the stronger movers in its sector for the day.

What is Fermenta Biotech’s market capitalisation?

Ans. Fermenta Biotech’s market capitalisation is Rs 1,471.99 Cr. That size places it above the industry median market cap of Rs 720.34 Cr, while still remaining far below the largest healthcare peers.

What does Fermenta Biotech Fundamental Analysis show?

Ans. Fermenta Biotech Fundamental Analysis shows a P/E of 23.67, P/B of 3.47, ROE of 18.36%, ROCE of 21.99%, EPS of Rs 20.55, book value of Rs 140.3 and dividend yield of 0.77%.

How does Fermenta Biotech compare with healthcare peers?

Ans. Fermenta Biotech trades at a lower P/E than Sun Pharma, Divi’s, Torrent and Cipla, while its ROE and ROCE are comparatively strong. Its market cap is also much smaller than those large-cap peers.

Which sector and industry does Fermenta Biotech belong to?

Ans. Fermenta Biotech belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. That context matters because valuation, return ratios and peer pricing can differ sharply across listed pharmaceutical companies.

Should investors track Fermenta Biotech Share Price on Univest?

Ans. Investors tracking Fermenta Biotech Share Price can use Univest to follow live price updates, market cap, valuation ratios, sector context and peer comparison in one place. It helps organise market information without making a recommendation.

Track Fermenta Biotech Share Price on Univest

Use Fermenta Biotech Ltd. (FERMENTA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Investors can track Fermenta Biotech Share Price on Univest for the latest share price update, market cap, valuation ratios, sector comparison, peer context and key market insights. The platform helps readers monitor Fermenta Biotech Share Price Today, Fermenta Biotech Stock News and Fermenta Biotech Stock Performance without depending on scattered market references.